Search research articles
Contact Us
Filters
Showing results (41-50 of 111) with videos related to
Page
of 12
Sort By:
Italian Journal of Dermatology and Venereology
|
February 13, 2025
Treating psoriatic arthritis in the early phase: proposal for a shared dermatological and rheumatological therapeutic intervention with biologics and targets synthetic disease-modifying immunosuppressive drugs
Andrea Picchianti Diamanti, Marco Galluzzo, Annunziata Dattola, et al.
International Journal of STD & AIDS
|
September 22, 2018
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO<sub>2</sub> ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial
Mario Puviani, Marco Galluzzo, Marina Talamonti, et al.
Expert Opinion on Biological Therapy
|
March 27, 2023
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
Marco Galluzzo, Lorenzo Marcelli, Laura Vellucci, et al.
Italian Journal of Dermatology and Venereology
|
May 21, 2019
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy
Sara Mazzilli, Alessandro Giunta, Marco Galluzzo, et al.
Immunology Letters
|
October 22, 2013
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis
Andreea Nicoleta Boca, Marina Talamonti, Marco Galluzzo, et al.
Journal of Clinical Medicine
|
January 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis
Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli, et al.
Skin Health and Disease
|
June 7, 2024
Dupilumab-associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report
Marco Galluzzo, Lorenzo Tofani, Sara Spelta, et al.
Vaccines
|
November 24, 2022
Allelic Variants of HLA-C Upstream Region, <i>PSORS1C3</i>, <i>MICA</i>, <i>TNFA</i> and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis
Martina Morelli, Marco Galluzzo, Claudia Scarponi, et al.
The Journal of Dermatology
|
April 16, 2025
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study
Edoardo Mortato, Lorenzo Marcelli, Lorenzo Tofani, et al.
Journal of Clinical Medicine
|
April 13, 2024
Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study
Claudia Paganini, Virginia Maffei, Laura Vellucci, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 111) with videos related to
Sort By:
Page
of 12
Italian Journal of Dermatology and Venereology
|
February 13, 2025
Treating psoriatic arthritis in the early phase: proposal for a shared dermatological and rheumatological therapeutic intervention with biologics and targets synthetic disease-modifying immunosuppressive drugs
Andrea Picchianti Diamanti, Marco Galluzzo, Annunziata Dattola, et al.
International Journal of STD & AIDS
|
September 22, 2018
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO<sub>2</sub> ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial
Mario Puviani, Marco Galluzzo, Marina Talamonti, et al.
Expert Opinion on Biological Therapy
|
March 27, 2023
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
Marco Galluzzo, Lorenzo Marcelli, Laura Vellucci, et al.
Italian Journal of Dermatology and Venereology
|
May 21, 2019
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy
Sara Mazzilli, Alessandro Giunta, Marco Galluzzo, et al.
Immunology Letters
|
October 22, 2013
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis
Andreea Nicoleta Boca, Marina Talamonti, Marco Galluzzo, et al.
Journal of Clinical Medicine
|
January 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis
Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli, et al.
Skin Health and Disease
|
June 7, 2024
Dupilumab-associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report
Marco Galluzzo, Lorenzo Tofani, Sara Spelta, et al.
Vaccines
|
November 24, 2022
Allelic Variants of HLA-C Upstream Region, <i>PSORS1C3</i>, <i>MICA</i>, <i>TNFA</i> and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis
Martina Morelli, Marco Galluzzo, Claudia Scarponi, et al.
The Journal of Dermatology
|
April 16, 2025
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study
Edoardo Mortato, Lorenzo Marcelli, Lorenzo Tofani, et al.
Journal of Clinical Medicine
|
April 13, 2024
Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study
Claudia Paganini, Virginia Maffei, Laura Vellucci, et al.
Page
of 12